找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

1234567
返回列表
打印 上一主題 下一主題

Titlebook: RNA Interference and CRISPR Technologies; Technical Advances a Mouldy Sioud Book 2020 Springer Science+Business Media, LLC, part of Springe

[復(fù)制鏈接]
樓主: 轉(zhuǎn)變
61#
發(fā)表于 2025-4-1 02:12:49 | 只看該作者
62#
發(fā)表于 2025-4-1 07:34:39 | 只看該作者
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing Reagents, as continual efforts are being made to optimize ON efficacy. Over the years, RNA interference (RNAi) has become one of the main tools used to inhibit RNA expression across a wide variety of species. Efforts have been made to improve the exogenous delivery of the double-stranded RNA components to th
63#
發(fā)表于 2025-4-1 12:00:29 | 只看該作者
Preparation, Determination of Activity, and Biodistribution of Cholesterol-Containing Nuclease-Resiw molecular weight drugs. Despite significant progress in this area, the potential for therapeutic use of RNAi in humans is limited due to the lack of efficient delivery systems. Bioconjugation is one of the most promising methods for delivering siRNA to cells and tissues, since conjugation of siRNA
64#
發(fā)表于 2025-4-1 16:09:40 | 只看該作者
Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy,rating with other therapeutics; however, transporting siRNA and other active ingredients to the same location at the same time is challenging. Here, we report a novel multifunctional nanodelivery platform by sequentially layering several functional ingredients, such as siRNAs, microRNAs, peptides, a
65#
發(fā)表于 2025-4-1 20:55:51 | 只看該作者
66#
發(fā)表于 2025-4-1 23:06:46 | 只看該作者
Delivery of Functional Small RNAs via Extracellular Vesicles In Vitro and In Vivo,EVs have recently gained significant interest as a promising material for delivery of therapeutics. Small RNAs, including small interfering RNA (siRNA) and microRNA (miRNA), provide a great therapeutic strategy for treating human diseases. However, it remains a challenge to deliver unconjugated smal
67#
發(fā)表于 2025-4-2 04:13:17 | 只看該作者
1234567
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 13:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
深水埗区| 司法| 吉首市| 丰原市| 洛宁县| 边坝县| 黑龙江省| 灯塔市| 济阳县| 长泰县| 长乐市| 台安县| 保亭| 梁山县| 金坛市| 肃宁县| 色达县| 青冈县| 深圳市| 深州市| 剑河县| 道孚县| 阳泉市| 徐闻县| 乌鲁木齐市| 洞头县| 武威市| 滕州市| 鲁甸县| 吴江市| 金门县| 江门市| 雷波县| 乐亭县| 嘉兴市| 绥化市| 彭州市| 宜兰市| 平乡县| 响水县| 普陀区|